drugset / Trial / NCT07655570
Pilot Study of Ivonescimab in Advanced/Metastatic Cutaneous Angiosarcoma
NaSingle-groupOpen-labelTreatment
Summary
This is a pilot study evaluating the efficacy and safety of ivonescimab in subjects with advanced or metastatic cutaneous angiosarcoma who have previously been treated with taxane-based chemotherapy.
Timeline
- Start
- 2026-11-30
- Primary completion
- 2027-05-11
- Completion
- 2029-05-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ivonescimab | Monoclonal antibody | 20 mg/kg | Intravenous |